| Mon, Nov 30, 2009 | | • | Nektar names Masuoka chief medical officer
at bizjournals.com (Mon, Nov 30)
| | • | NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Mon, Nov 30)
| | • | Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
PR Newswire (Mon, Nov 30)
| | Fri, Nov 13, 2009 | | • | Abbott: Brave or Stupid?
at Motley Fool (Fri, Nov 13)
| | • | AstraZeneca Beats, Raises
Zacks.com (Fri, Nov 13)
| | Tue, Nov 10, 2009 | | • | NEKTAR THERAPEUTICS Financials
EDGAR Online Financials (Tue, Nov 10)
| | Thu, Nov 5, 2009 | | • | New Star Analyst Rankings for Nektar Therapeutics
StarMine (Thu, Nov 5)
| | • | NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | Nektar Therapeutics Financial Results Call scheduled for 5:00 pm ET today
CCBN (Wed, Nov 4)
| | • | NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
EDGAR Online (Wed, Nov 4)
| | • | Nektar Therapeutics Reports Third Quarter 2009 Financial Results
PR Newswire (Wed, Nov 4)
| | • | Q3 2009 Nektar Therapeutics Earnings Release - Time Not Supplied
CCBN (Wed, Nov 4)
| | Thu, Oct 29, 2009 | | • | Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets
PR Newswire (Thu, Oct 29)
| | Wed, Oct 28, 2009 | | • | Nektar Completes Enrollment Ahead of Schedule in Phase 2 Clinical Trial Evaluating NKTR-102 in Patients with Platinum-Resistant Ovarian Cancer
PR Newswire (Wed, Oct 28)
| | Tue, Oct 27, 2009 | | • | Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
PR Newswire (Tue, Oct 27)
| | Thu, Oct 15, 2009 | | • | This Partnership Will Go No Further
at Motley Fool (Thu, Oct 15)
| | Wed, Oct 14, 2009 | | • | Progenics: Investors Are Right To Be Wary
at Seeking Alpha (Wed, Oct 14)
| | Tue, Oct 13, 2009 | | • | NEKTAR THERAPEUTICS Files SEC form 8-K, Regulation FD Disclosure
EDGAR Online (Tue, Oct 13)
| | Mon, Oct 12, 2009 | | • | Nektar Presents Favorable Data
Zacks.com (Mon, Oct 12)
| | Sat, Oct 10, 2009 | | • | Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix
PR Newswire (Sat, Oct 10)
|
Add NKTR News to My Yahoo!:
 
| |
|
0.22% Nasdaq 
Headlines
